Anti-Cancer Drug Prices May Fall by up to 70% as Govt Plans Trade Margin Cap
The cap could cut maximum retail prices by as much as 70%, according to Department of Pharmaceuticals sources.
- India is capping trade margins for expensive cancer drugs at 30% of MRP, targeting medicines where the impact on patients is greatest. The move aims to reduce steep mark-ups in the market.
- The Department of Pharmaceuticals built this policy on a 2019 pilot program that capped trade margins on 42 cancer medicines. The department seeks to rein in steep mark-ups in the market.
- A committee headed by the Director General of Health Services is selecting frequently used, expensive drugs approved for cancer treatment in India. The committee is expected to finalize the list soon.
- The measure will take effect within 10 days, with maximum retail prices for some patented cancer drugs potentially dropping by as much as 70%. The move could deliver estimated annual savings of Rs 2,500 crore.
- Extending the 30% cap to cheaper drugs could disrupt supply, so the Department of Pharmaceuticals is avoiding a blanket cap to maintain distribution networks. The targeted approach ensures continued availability of life-saving medicines.
21 Articles
21 Articles
Cancer medicine prices may drop 70 per cent as government plans trade margin cap
Anti-cancer drug prices may fall by up to 70 per cent as the government considers capping trade margins at 30 per cent of MRP for non-scheduled medicines. The move could help reduce cancer treatment costs and save patients Rs 2,500 crore annually.
aninews.in
KalingaTVAnti-cancer drug prices may fall by up to 70% as govt plans trade margin cap
Prices of anti-cancer drugs may fall by up to 70 per cent as the government is moving to cap trade margins at 30 per cent of the Maximum Retail Price (MRP) for non-scheduled anti-cancer medicines, according to official sources.
Cancer drug prices to drop as govt caps trade margin at 30pc
The Indian government has decided to cap trade margins on all non-scheduled anti-cancer drugs at 30 per cent of their maximum retail price. This move aims to improve affordability and ensure continued availability of these life-saving medicines, potentially saving cancer patients an estimated Rs 2,500 crore annually. The decision, expected to be implemented later this month, will affect 110 anti-cancer drugs, including 35 patented ones.
Cancer Medicines To Get Cheaper: Govt Caps Trade Margin at 30%, MRP May Drop up to 70% | 📰 LatestLY
The government is set to cap trade margins at 30% on expensive cancer drugs, including some patented medicines. MRPs could fall by up to 70%, and the measure is expected to take effect within 10 days. 📰 Cancer Medicines To Get Cheaper: Govt Caps Trade Margin at 30%, MRP May Drop up to 70%.
Coverage Details
Bias Distribution
- 89% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
